ArticleVaccine2026

Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates.

Jason R Andrews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.